Following unaffected relatives of people with inflammatory bowel disease over time
Follows close relatives of people with Crohn's or colitis who lack the disease.
Key facts
- Who runs it
- Massachusetts General Hospital
- Where
- Boston, United StatesSee the site
- Trial code
- Registry title
- Family Members at INcreased-risk for Developing Inflammatory Bowel Disease
- Status
- Recruiting
- People taking part
- 50 people, planned
- Started
- 18 Dec 2024
- Expected to end
- Dec 2034
- Type of study
- Observational
- Record updated
- 7 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people aged 14 or older who do not have IBD but have at least one close blood relative (parent, brother, sister or child) with IBD. They are followed over time.
- Age
- 14 years or older
- Sex
- All sexes can join
- Disease stage
- Must not have IBD or clinical signs or symptoms of IBD.
Main reasons for not taking part
- Already diagnosed with ulcerative colitis, Crohn's disease or IBD-unclassified
- Signs or symptoms of IBD found at the pre-screening interview
- Cannot give informed consent
- Cannot complete all study visits and procedures
- Cannot understand and complete the study questionnaires
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Ability to give informed consent
- Ability to complete all study visits and study-related procedures
- Ability to understand and complete study questionnaires
- Must have at least one first-degree relative with inflammatory bowel disease (Crohn's disease, ulcerative colitis, or IBD-unclassified)
- Age ≥ 14
Who cannot take part
- Individuals with existing diagnoses of inflammatory bowel disease (ulcerative colitis, Crohn's disease, or IBD-unclassified)
- Evidence of clinical signs or symptoms of IBD, which will be identified on pre-screening interview with the study coordinator
Where in United States
- Massachusetts General HospitalBoston, United StatesContact: Emily W Lopes, MD, MPHTaking people
About the trial
What the trial wants to find out
First-degree relatives of people with inflammatory bowel disease ("IBD," including Crohn's disease and ulcerative colitis) have an increased risk for developing IBD themselves. This study will follow unaffected first-degree relatives (who do not have IBD) over time to understand if their behaviors, diet, and biomarkers for IBD can help predict who gets IBD and if IBD can be prevented in these high-risk individuals. Participants will be asked once per year to complete a questionnaire and have their blood, stool, and urine collected. The anticipated length of the study (registry) is approximately 10 years or longer. Parts of this study, such as the questionnaires and stool and urine collection, may be done from home, while other parts, such as the blood draw, will need to be done from Massachusetts General Hospital.
The group in the trial
- Individuals who have a parent, sibling, or child with IBD but who do not have IBD themselves
Adult and adolescent (greater than 14 years of age) first-degree relatives (parents, siblings, or children) of patients with inflammatory bowel disease (including Crohn's disease, ulcerative colitis, or inflammatory bowel disease-unclassified/indeterminate colitis) but who do not have inflammatory bowel disease themselves.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Family Members at INcreased-risk for Developing Inflammatory Bowel Disease (FIND-IBD)
- Plain-language title
- Following unaffected relatives of people with inflammatory bowel disease over timeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 7 October 2026